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terest: Endologix; Type of Relationship: Consultant.Effects on Renal Function After Percutaneous Mechanical
Thrombectomy Using AngioJet
Matthew R. Abate, MD, Dillon Burks, BS, Ahsan Ali, MD, Matthew R.
Smeds, MD, Guillermo A. Escobar, MD. University of Arkansas for
Medical Sciences, Little Rock, Ark
Objectives: Percutaneousmechanical thrombectomy (PMT) is a popu-
lar and useful tool for thrombus removal in acute thrombotic syndromes. The
AngioJet uses high-pressure spray to break up and aspirate thrombus in addi-
tion to delivering plasminogen activators. This is known to cause hemolysis,
and all practitioners have noted periprocedural hematuria. Despite this, to
our knowledge, there is no study evaluating the consequences to renal function
after using this device. We sought to determine the incidence of acute kidney
injury, and associated risk factors after using the AngioJet for thrombolysis.
Methods: With Investigational Review Board approval, we retrospec-
tively reviewed a prospectively maintained database of all patients managed
by the vascular surgery service from 2009-2012 with procedural codes
describing thrombolysis (Current Procedural Terminology [CPT] codes
37201, 37187, 37209, and 75898), and/or PMT (CPT 37187). We iden-
tiﬁed those treated with the AngioJet and reviewed demographics, indica-
tions, laboratory values before and after the procedure (up to 3 days), and
determined the incidence of acute kidney injury (AKI). AKI was deﬁned
as an increase in creatinine (Cr) >25% of baseline within 24 to 72 hours.
Patients on dialysis before AngioJet or without laboratory values before
and 24 to 72 hours after treatment were excluded.
Results: We identiﬁed 144 lysis procedures, and 53 were treated with
the AngioJet. Average age was 50 (range, 87-20; median, 49). Arterial
thrombus was the indication in 68%; venous in the rest. AKI occurred in 15Table. Multivariate analysis of preoperative factors affecting outcomes with low
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BMI, Body mass index; CAD, coronary artery disease; CI, conﬁdence interval; Cof 53 (28%). Baseline Cr in AKI and non-AKI patients was similar, whereas
Cr after AngioJet was not (P ¼ .01). Only four patients had a baseline Cr
>1.4 (two in each group). Average age of the AKI group was 54 (range 36-
74, medium 49), 47% were male, and only one had a baseline Cr >1.4 mg/
dL (not signiﬁcant for all). Average creatinine increase from baseline in AKI
group was 0.5 mg/dL (167% rise; P ¼ .003) compared with e0.07mg/dL
(NS) in non-AKI patients. When compared with 53 lysis cases that did not
use AngioJet, the Cr change in the AngioJet group was higher (P ¼ .03).
Conclusions: This preliminary study suggests that AKI may occur in
more than one-quarter of patients treated with the AngioJet, independently of
traditional risk factors for AKI (diabetes, baseline Cr, and age). This risk may
be due to hemolysis and is under-reported in the literature. Prospective studies
and long-term consequences should be undertaken to better deﬁne this risk.
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Randall De Martino, MD, Mark Fleming, MD, Peter Gloviczki, MD,
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Objectives: We have previously reported trends of decreasing amputa-
tions along with increasing endovascular interventions for peripheral arterial dis-
ease (PAD) in a deﬁned population between 1990 and 2009. The aim of this
studywas to analyzepreoperative risk factors affectingoutcomes in thesepatients.
Methods: A retrospective cohort study of residents of a single
county was conducted. Procedures were identiﬁed by International Clas-
siﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-
CM)/Current Procedural Terminology codes and data collecteder extremity revascularization procedures
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(MALE), major amputations (AMPU), amputation-free survival (AFS)
and mortality. Statistical analysis was performed using the Cox-propor-
tional hazards model.
Results: A total of 1906 lower extremity procedures were performed
in 957 limbs with PAD; 622 patients (males, 363; females, 259) with a
mean age 67.8 years, (range, 27-98). These included 713 open, 610 endo-
vascular), and 75 hybrid revascularizations; and 192 primary and 340 sec-
ondary amputations. Half the procedures (52%) were performed for
critical limb ischemia (CLI) and 7% were emergencies. The study popula-
tion was predominantly white (96%); comorbidities included dyslipidemia
in 62%, coronary artery disease in 47%, 26% with a prior intervention, cur-
rent smoking in 42%, diabetes mellitus in 37%, and renal insufﬁciency
(serum creatinine >2.0 mg/dL) in 8%. On univariate analysis the most sig-
niﬁcant risk factor associated with MALE and AMPU was presence of CLI
(hazard ratio [HR], 3.1/7.1), followed by renal insufﬁciency on dialysis
(HR, 3.2/5.2), emergency procedure (HR, 3.0/2.5), diabetes mellitus
(HR, 2.0/3.9), and congestive heart failure (HR, 1.9/3.4). The prevalence
of signiﬁcant obesity (body mass index >35 kg/m2) increased from 6% in
the 5-year interval of 1990 to 1994 to 12% in 2005 to 2009, and was
also signiﬁcantly associated with MALE, AMPU, and AFS (HR, 2.4/4.3/
1.5). In addition, factors associated with AFS and mortality included, age
>75 years (HR, 2.4/2.8), anemia (HR, 2.7/2.8), and coronary artery dis-
ease without intervention (HR, 1.6/1.8). Table I summarizes multivariate
analysis for factors signiﬁcantly associated with all end points.
Conclusions: This population-based study conﬁrms the traditional
risk factors for adverse outcomes following revascularization for PAD. Se-
vere obesity is emerging as an important risk factor not previously reported
especially in light of increasing incidence in the population.
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Objectives: This study compared early-term and midterm outcomes
of polytetraﬂuoroethylene-covered stent (CS) vs bare-metal stent (BMS),
in the primary treatment of severe TransAtlalntic Inter-Society Consensus
for the Management of Peripheral Arterial Disease II (TASC II) C and D
iliac artery obstructive lesions.
Methods: Between January 2009 and July 2014, 134 patients under-
went 177 iliac arteries stenting. A CS was implanted in 91 iliac arteries
(51%) and BMS in 86 (49%). All patients were prospectively enrolled in a dedi-
cated database. Thirty-day outcomes, midterm patency, and limb salvage were
compared; follow-up results were analyzed with Kaplan-Meier curves. Clinical
presentation, lesion site, extension and laterality, were evaluated for their asso-
ciation with patency in the two groups using multiple logistic regressions.
Results: Overall, mean age was 69 6 9.27, with a Society for Vascular
Surgery comorbidity score of 0.896 0.55 with no differences after stratiﬁca-
tion by CS and BMS (P ¼ .7); iliac lesions were classiﬁed as TASC II C in 96
(54%) and D in 81 (46%), with 89 being monolateral and 44 bilateral (67% vs
33%). Comparing CS and BMS, technical success was 99% in both groups (P
¼ .2); 30-day cumulative rate of surgical complications (4% vs 7%; P ¼ .51),
mortality (0% vs 1.3%; P ¼ .34), and morbidity (3% vs 4.5%; P ¼ .63) were
equivalent. At 18 months, the primary patency of CS vs BMS was similar
(95% vs 92%; P ¼ .74) and was maintained after stratiﬁcation by TASC II
C (97% vs 94%) and D (91% vs 89%); secondary patency was 97% vs 93%
(P ¼ .91) and limb salvage was 99% and 98% (P ¼ .25), respectively. Multi-
variate analysis indicated that CS in long-segment stenosis involving both the
common and external iliac artery was positive predictor of patency (odds ra-
tio, 2.8; 95% conﬁdence interval, 1.1-8.6; P ¼ .03).
Conclusions: Overall, the use of CS for severe iliac lesions has similar
early-term and midterm outcomes compared with BMS. In a subcategory of
TASC II D lesions, with long-segment severe stenosis of both common and
external iliac artery, CS should be considered as primary line of treatment.
Author Disclosures: M. Piazza: None; L. Milan: None; P. Scrivere:
None; S. Bonvini: None; J. J. Ricotta: None; F. Grego: None; M.
Antonello: None.Increased Pulse Pressure in Patients with Critical Limb
Ischemia Predicts Procedural Complications and
Reinterventions
Dominique B. Buck, MD, Vanessa Lee, Jeremy D. Darling, BA, John C.
McCallum, MD, Sara L. Zettervall, MD, Peter A. Soden, MD, Marc L.
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Objectives: Pulse pressure (PP) is a noninvasive measure of arterial stiff-
ness. Because it reﬂects lower arterial elasticity and compliance, PP is thought
to limit the success of endovascular interventions. In this study, we sought to
determine whether increased PP was associated with worse long-term out-
comes in patients undergoing endovascular infrapopliteal interventions.
Methods: From 2004 to 2014, 596 patients underwent infrapopliteal
angioplasty for critical limb ischemia (CLI). PP was derived from blood pres-
sure measurements obtained #24 hours of the procedure. Patients were
divided into two groups, those with PP <80 and those with PP $80. Out-
comes included procedural complications, reintervention, major amputation,
and mortality. Predictors were identiﬁed using multivariable logistic regres-
sion, Cox regression models, and Kaplan-Meier survival estimates.
Results: Of 596 patients, 323 patients had a PP <80 and 273 had a
PP $80. Patients with PP $80 were more likely to have hypertension (88%
vs 82%; P ¼ .04); however, no other signiﬁcant differences in patient demo-
graphics and comorbidities were identiﬁed. Three-year reintervention rates
and mortality were signiﬁcantly more common in patients with PP $80
(29% vs 20%, P ¼ .02; 55% vs 45%, P ¼ .01, respectively; Table). A Cox pro-
portional hazards model illustrated that, over time, mortality was signiﬁ-
cantly higher in patients with PP $80 (hazard ratio, 1.1; 95% conﬁdence
interval [CI], 1.3-2.0). In multivariable analysis, a PP $80 was a predictor
of procedural complications (odds ratio, 1.8; 95% CI, 1.2-2.8; P # .01) and
reinterventions (odds ratio, 1.7; 95% CI, 1.2-2.6, P # .01).
Conclusions: Increased PP is associated with increased procedural
complication rates, reintervention, and 3-year mortality, suggesting that
arterial stiffness plays an important role in outcomes after endovascular
intervention for CLI.
Table. Outcomes for patients with pulse pressure (PP) <80 and PP $80
PP < 80 PP $ 80
Outcomesa (n ¼ 323) (n ¼ 273) P valueStent 91 (28) 91 (33) .17
Procedural complications 46 (14) 60 (22) .01
Length of stay, days 8.1 [7.7] 6.1 [6.4] <.01
3-year
Reintervention 58 (20) 69 (29) .02b
bRepeat PTA/S 34 (12) 48 (16) .15
bBypass 23 (8) 32 (13) .04Restenosis 79 (27) 82 (34) .07bMajor amputation 45 (15) 30 (12) .36bMortality 145 (45) 150 (55) .01bPTA/S, Percutaneous transluminal angioplasty/stenting.
aData are shown as number (%) or mean [standard deviation].
bBased on proportional hazards.
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Objectives: Carotid endarterectomy (CEA) is commonly performed
by general surgeons, cardiothoracic surgeons, neurosurgeons, and vascular
surgeons, with each specialty having differences in residency structure, oper-
ative experience, and subspecialty training. The aim of this study was to eval-
uate the effect of surgeon specialty on outcomes after elective CEA.
Methods: Patients who underwent elective CEA were identiﬁed from
the 2007 to 2009 Nationwide Inpatient Sample (NIS). Physician identiﬁers
in the NIS were used to determine surgical specialty and operative experi-
ence. Multivariate analysis adjusted for surgeon experience and mortality
risk was used to compare differences in demographics, complications, out-
comes, and hospital covariates.
